LoginRegister

    Granules India gets EIR from USFDA for Vizag OmniChem facility

    Written by Ruby Khatun Khatun   |  

    New Delhi: Drug firm Granules India said it has received Establishment Inspection Report (EIR) from the US health regulator for the OmniChem facility at Vizag, Andhra Pradesh.


    OmniChem facility is operated by 50:50 joint venture of Granules India and Ajinimoto OmniChem N V, it said in a filing on BSE.


    The United States Food and Drug Administration (USFDA) has issued EIR for the company's OmniChem facility, it added.


    "This facility was inspected by the USFDA in December 2016 and there were seven observations during the inspection. The facility manufactures Active Pharmaceutical Ingredients (API) intermediates," Granules India said.

    active pharmaceutical ingredientsAjinimoto OmniChem N VAndhra PradeshEIREstablishment Inspection ReportGranules Indiajoint ventureOmniChem facilityseven observationsUSFDAVizag
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X